Protective effect of p-methoxyl-diphenyl diselenide in lethal acute liver failure induced by lipopolysaccharide and d-galactosamine in mice

Fundamental and Clinical Pharmacology

Volumn 23, Issue 6, 2009, Pages 727-734

  Wilhelm, E A ^a   Jesse, C R ^a   Nogueira, C W ^a  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

Author keywords

D galactosamine and lipopolysaccharide; Hepatic damage; Oxidative stress; Selenium

Indexed keywords

4 METHOXYLDIPHENYL DISELENIDE; ALANINE AMINOTRANSFERASE; ASCORBIC ACID; ASPARTATE AMINOTRANSFERASE; CATALASE; GALACTOSAMINE; GLUTATHIONE TRANSFERASE; LIPOPOLYSACCHARIDE; ORGANOSELENIUM DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EUTHANASIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; ENZYME ACTIVITY; HISTOPATHOLOGY; INFLAMMATORY CELL; LIPID PEROXIDATION; LIVER FAILURE; LIVER HEMORRHAGE; LIVER NECROSIS; LIVER PROTECTION; MALE; MEGALOCYTOSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; TISSUE SECTION;

ADMINISTRATION, ORAL; ALANINE TRANSAMINASE; ANIMALS; ANTIOXIDANTS; ASCORBIC ACID; ASPARTATE AMINOTRANSFERASES; BENZENE DERIVATIVES; CATALASE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG-INDUCED LIVER INJURY; GALACTOSAMINE; GLUTATHIONE TRANSFERASE; INJECTIONS, INTRAPERITONEAL; LIPOPOLYSACCHARIDES; LIVER FAILURE, ACUTE; MALE; MICE; ORGANOSELENIUM COMPOUNDS;

EID: 70449487243     PISSN: 07673981     EISSN: 14728206     Source Type: Journal    
DOI: 10.1111/j.1472-8206.2009.00759.x     Document Type: Article

References (42)

1. Shakil A.O., Kramer D., Mazariegos G., Fung J.J., Rakela J. Acute liver failure: clinical features, outcome analysis, and applicability of prognostic criteria. Liver Transpl. (2000) 6 163 169.
2. Day H.L., Taylor R.M. The liver part 5: acute liver failure. Nurs. Times (2005) 102 26 27.
3. Gaté L., Paul J., Ba G.N., Tew K.D., Tapiero H. Oxidative stress induced in pathologies: the role of antioxidants. Biomed. Pharmacother. (1999) 53 169 180.
4. Bray T.M. Dietary antioxidants and assessment of oxidative stress. Nutrition (2000) 16 578 581.
5. Mayer M., Caselman W.H., Schulter V., Schreck R., Hofschneider P.H., Baeuerle P.A. Hepatitis B virus transactivator MHBs: activation of NF-κB, selective inhibition of antioxidants and integral membrane localization. EMBO J. (1993) 11 2991 2998.
6. Markov A.K., Farias L.A., Bennett W.S., Subramony C., Mihas A.A. Prevention of galactosamine-induced hepatotoxicity in rats with fructose-1,6-diphosphate. Pharmacology (1991) 43 310 317.
7. Arvelo M.B., Cooper J.T., Longo C. et al. A20 protects mice from D-galactosamine/lipopolysaccharide acute toxic lethal hepatitis. Hepatology (2002) 35 535 543.
8. Shiratori Y., Kawase T., Shiina S. et al. Modulation of hepatotoxicity by macrophages in the liver. Hepatology (1988) 8 815 821.
9. Bruck R., Hussein A., Schey R. et al. Pyrrolidine dithiocarbamate protects against thioacetamide-induced fulminant hepatic failure in rats. J. Hepatol. (2002) 36 370 377.
10. Arteel G.E., Sies H. The biochemistry of selenium and glutathione system. Environ. Toxicol. Pharmacol. (2001) 10 153 158.
11. Moro A.V., Nogueira C.W., Barbosa N.B., Menezes P.H., da Rocha J.B., Zeni G. Highly stereoselective one-pot procedure to prepare bis- and tris-chalcogenide alkenes via addition of disulfides and diselenides to terminal alkynes. J. Org. Chem. (2005) 70 5257 5268.
12. Muller A., Cadenas E., Graf P., Sies H. A novel biologically active seleno-organic compound I. Glutathione peroxidase-like activity in vitro and antioxidant capacity of PZ 51 (Ebselen). Biochem. Pharmacol. (1984) 33 3235 3239.
13. Rossato J.L., Ketzer L.A., Centurião F.B. et al. Antioxidant properties of new chalcogenides against lipid peroxidation in rat brain. Neurochem. Res. (2002) 27 297 303.
14. Nogueira C.W., Zeni G., Rocha J.B.T. Organoselenium and organotellurium compounds: toxicology and pharmacology. Chem. Rev. (2004) 104 6255 6286.
15. Barbosa N.B.V., Rocha J.B.T., Wondracek D.C. et al. Diphenyl diselenide reduces temporarily hyperglycemia: Possible relationship with oxidative stress. Chem. Biol. Interact. (2006) 163 230 238.
16. Borges L.P., Borges V.C., Moro A.V. et al. Protective effect of diphenyl diselenide on acute liver damage induced by 2-nitropropane in rats. Toxicology (2005) 210 1 8.
17. Borges L.P., Nogueira C.W., Panatieri R.B., Rocha J.B.T., Zeni G. Acute liver damage induced by 2-nitropropane in rats: Effect of diphenyl diselenide on antioxidant defenses. Chem. Biol. Interact. (2006) 160 99 107.
18. Paulmier C. Selenium reagents and intermediates: Organic synthesis, Pergamon, Oxford, 1986.
19. Takamura M., Matsuda Y., Yamagiwa S. et al. An inhibitor of c-Jun NH2-terminal kinase, SP600125, protects mice from D-galactosamine/ lipopolysaccharide-induced hepatic failure by modulating BH3-only proteins. Life Sci. (2007) 80 1335 1344.
20. Wills P.J., Asha V.V. Protective effect of Lygodium flexuosum (L.) Sw. (Lygodiaceae) against D-galactosamine induced liver injury in rats. J. Ethnopharmacol. (2006) 108 116 123.
21. Reitman S., Frankel S. A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases. Am. J. Clin. Pathol. (1957) 28 56 63.
22. Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. (2006) 95 351 358.
23. Jacques-Silva M.C., Nogueira C.W., Broch L.C., Rocha J.B.T. Diphenyl diselenide and ascorbic acid changes deposition of selenium and ascorbic acid in brain of mice. Pharmacol. Toxicol. (2001) 88 119 125.
24. Aebi H. Catalase in vitro. Methods Enzymol. (1984) 105 121 126.
25. Habig W.H., Pabst M.J., Jakoby W.B. Glutathione S-transferases The first enzymatic step in mercapturic acid formation. J. Biol. Chem. (1974) 249 7130 7139.
26. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principles of protein-dye binding. Anal. Biochem. (1976) 72 248 254.
27. Rahman T.M., Hodgson H.J. The effects of early and late administration of inhibitors of inducible nitric oxide synthase in a thioacetamide-induced model of acute hepatic failure in the rat. J. Hepatol. (2003) 38 583 590.
28. Nakama T., Hirono S., Moriuchi A. et al. Etoposide prevents apoptosis in mouse liver with Dgalactosamine/lipopolysaccharide-induced fulminant hepatic failure resulting in reduction of lethality. Hepatology (2001) 33 1441 1450.
29. Xiong Q., Hase K., Tezuka Y., Namba T., Kadota S. Acteoside inhibits apoptosis in D-galactosamine and lipopolysaccharide induced liver injury. Life Sci. (1999) 65 421 430.
30. Sun F., Hamagawa E., Tsutsui C. et al. Evaluation of oxidative stress during apoptosis and necrosis caused by D-galactosamine in rat. Biochem. Pharmacol. (2003) 65 101 107.
31. Sclafani L., Shimm P., Edelman J., Seifter E., Levenson S.M., Demetriou A.A. Protective effect of vitamin E in rats with acute liver injury. J. Parenter. Enteral. Nutr. (1986) 10 184 187.
32. Molander D.W., Wroblewski F., Ladue J.S. Serum glutamic oxalacetic transaminase as na indexo of hepatocellular integrity. J. Lab. Clin. Med. (1955) 46 831 839.
33. Zimmerman H.J., Seeff L.B. Enzymes in hepatic disease, in : Goodle E.L. (ed Diagnostic enzymology. Lea and Febiger, Philadelphia, pp. 1 38.
34. Goto T., Takeuchi S., Miura K. et al. Suramin prevents fulminant hepatic failure resulting in reduction of lethality through the suppression of NF-κB activity. Cytokine (2006) 33 28 35.
35. Niemela O., Parkkila S., Yla-Herttuala S. et al. Covalent protein adduct in the liver as a result of ethanol metabolism and lipid peroxidation. Lab. Invest. (1994) 70 537 546.
36. Paradis V., Mathurin P., Kollinger M. et al. In situ detection of lipid peroxidation in chronic hepatitis C: correlation with pathological features. J. Clin. Pathol. (1997) 50 401 406. (Pubitemid 27278444)
37. Liu K.Z., Man A., Shaw R.A., Liang B., Xu Z., Gong Y. Molecular determination of liver fibrosis by synchrotron infrared microspectroscopy. Biochim. Biophys. Acta (2006) 1758 960 967.
38. Vaca C.E., Wilhelm J., Harms-Ringdahl M. Studies on lipid peroxidation in rat liver nuclei and isolated nuclear membranes. Biochim. Biophys. Acta (1988) 958 375 587.
39. Baudrimont I., Betbeder A.M., Creppy E.E. Reduction of the ochratoxin A-induced cytotoxicity in Vero cells by aspartame. Arch. Toxicol. (1997) 71 290 298.
40. Ravikumar V., Shivashangari K.S., Devaki T. Effect of Tridax procumbens on liver antioxidant defense system during lipopolysaccharide-induced hepatitis in D-galactosamine sensitized rats. Mol. Cell. Biochem. (2005) 269 131 136.
41. Boyer T.D., Vessey D.A., Holcomb C., Saley N. Studies of the relationship between the catalytic activity and binding of non-substrate ligands by the glutathione S-transferases. Biochem. J. (1984) 217 179 185.
42. Adaramoyer O.A., Adeyemi E.O. Hepatoprotection of D-galactosamine-induced toxicity in mice by purified fractions from Garcinia kola seeds. Basic Clin. Pharmacol. Toxicol. (2006) 98 135 141.